Data is not available at this time.
Innovative Industrial Properties, Inc. (IIP) operates as a specialized real estate investment trust (REIT) focused on the regulated medical-use cannabis industry. The company acquires, owns, and manages properties leased to state-licensed cannabis operators, providing them with long-term, triple-net lease agreements. This model ensures stable rental income while shifting property maintenance and operational responsibilities to tenants. IIP primarily serves the U.S. market, capitalizing on the growing legalization of medical cannabis and the need for compliant, purpose-built facilities. As a pioneer in cannabis-focused real estate, IIP holds a first-mover advantage, with a portfolio concentrated in states with established medical cannabis programs. The company’s strategic focus on experienced operators mitigates tenant risk, while its REIT structure offers tax efficiencies and attractive dividend yields. IIP’s market position is strengthened by its deep industry relationships and ability to provide capital solutions to cannabis businesses, which often face limited access to traditional financing. The company’s niche specialization differentiates it from conventional REITs, positioning it as a key enabler of the cannabis industry’s infrastructure growth.
IIP reported revenue of $308.5 million for the latest fiscal period, reflecting its ability to generate steady income from its leased properties. Net income stood at $159.4 million, with diluted EPS of $5.53, underscoring strong profitability. Operating cash flow of $258.4 million highlights efficient cash generation, while capital expenditures of -$63.1 million indicate a focus on maintaining rather than aggressively expanding its portfolio.
The company’s earnings power is driven by its high-margin lease agreements and scalable operating model. With a disciplined approach to capital allocation, IIP maintains robust cash flow coverage for dividends and reinvestment. Its REIT structure ensures efficient capital deployment, with a focus on accretive acquisitions and tenant retention.
IIP’s balance sheet remains solid, with $146.2 million in cash and equivalents and total debt of $298.9 million, reflecting a conservative leverage profile. The company’s debt-to-equity ratio is manageable, supported by stable rental income and a diversified tenant base. Its financial health is further reinforced by strong liquidity and access to capital markets.
IIP has demonstrated consistent growth through strategic property acquisitions and lease escalations. The company pays a substantial dividend of $7.60 per share, appealing to income-focused investors. Future growth will likely hinge on further cannabis legalization and expansion into new markets, though regulatory risks remain a consideration.
With a market cap of $1.53 billion and a beta of 1.76, IIP is viewed as a higher-risk, higher-reward play within the REIT sector. Investors appear to price in growth potential from cannabis legalization, though volatility reflects regulatory uncertainties. The stock’s valuation multiples suggest optimism about its niche market positioning.
IIP’s strategic advantages include its first-mover status, specialized expertise, and strong tenant relationships. The outlook remains positive, supported by tailwinds in cannabis legalization and limited competition in its niche. However, regulatory changes and tenant credit risks could pose challenges. The company is well-positioned to capitalize on long-term industry growth.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |